Thyroid Hormone Replacement for Subclinical Hypothyroidism and Chronic Heart Failure (ThyroHeart-CHF)
Efficacy and Safety of Levothyroxine (L-T4) Replacement on Exercise Capability in Chronic Systolic Heart Failure Patients With Subclinical Hypothyroidism: A 24-week, Multi-center, Open Label, Randomized, Parallel Group Trial
Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital
A PHASE4 clinical study on Heart Failure and Subclinical Hypothyroidism, this trial is ongoing. The trial is conducted by Chinese Academy of Medical Sciences, Fuwai Hospital and has accumulated 8 data snapshots since 2017. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE4
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE4
-
Apr 2020 — Jan 2021 [monthly]
Unknown Status PHASE4
Status: Recruiting → Unknown Status
-
Jun 2018 — Apr 2020 [monthly]
Recruiting PHASE4
▶ Show 3 earlier versions
-
Apr 2018 — Jun 2018 [monthly]
Recruiting PHASE4
-
Mar 2018 — Apr 2018 [monthly]
Recruiting PHASE4
-
Apr 2017 — Mar 2018 [monthly]
Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Chinese Academy of Medical Sciences, Fuwai Hospital
- Henan Provincial People's Hospital
- The First Hospital of Hebei Medical University
- The Luhe Teaching Hospital of the Capital Medical University
- Tianjin Medical University Second Hospital
For direct contact, visit the study record on ClinicalTrials.gov .